A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines.
about
Knockdown of hTERT and Treatment with BIBR1532 Inhibit Cell Proliferation and Invasion in Endometrial Cancer Cells.Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drugSynergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer CellsInhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells.Telomerase reverse transcriptase mediates EMT through NF-κB signaling in tongue squamous cell carcinoma.Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells.
P2860
A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A combination of the telomeras ...... n in breast cancer cell lines.
@en
type
label
A combination of the telomeras ...... n in breast cancer cell lines.
@en
prefLabel
A combination of the telomeras ...... n in breast cancer cell lines.
@en
P2093
P2860
P1433
P1476
A combination of the telomeras ...... n in breast cancer cell lines.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11523-015-0364-Y
P577
2015-04-29T00:00:00Z
P5875
P6179
1024356573